Sleep researchers at Mount Sinai have made a major breakthrough by developing a new model that analyzes sleep study data using generative artificial intelligence. This advance provides a robust profile of patient risk for not just cardiovascular outcomes, but all-cause mortality, daytime sleepiness, and significant obstructive sleep apnea. The first-of-its-kind software tool is currently being licensed to sleep researchers, with plans to commercialize it once fully validated and approved by the Food and Drug Administration.